Cas 1123783-56-1,3-{[(4-bromophenyl)methyl]amino}-2-(4-fluorophenyl)-3H,4H-thieno[2,3-d]pyrimidin-4-one

1123783-56-1

Post Buying Request

Basic information

Product Name: 3-{[(4-bromophenyl)methyl]amino}-2-(4-fluorophenyl)-3H,4H-thieno[2,3-d]pyrimidin-4-one
Synonyms: 3-{[(4-bromophenyl)methyl]amino}-2-(4-fluorophenyl)-3H,4H-thieno[2,3-d]pyrimidin-4-one
CAS NO:1123783-56-1
Molecular Formula:
Molecular Weight: 430.3
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-{[(4-bromophenyl)methyl]amino}-2-(4-fluorophenyl)-3H,4H-thieno[2,3-d]pyrimidin-4-one(CAS DataBase Reference)
NIST Chemistry Reference: 3-{[(4-bromophenyl)methyl]amino}-2-(4-fluorophenyl)-3H,4H-thieno[2,3-d]pyrimidin-4-one(1123783-56-1)
EPA Substance Registry System: 3-{[(4-bromophenyl)methyl]amino}-2-(4-fluorophenyl)-3H,4H-thieno[2,3-d]pyrimidin-4-one(1123783-56-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1123783-56-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1123783-56-1 Suppliers

Recommended suppliers

1123783-56-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1123783-56-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,3,7,8 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1123783-56:
(9*1)+(8*1)+(7*2)+(6*3)+(5*7)+(4*8)+(3*3)+(2*5)+(1*6)=141
141 % 10 = 1
So 1123783-56-1 is a valid CAS Registry Number.

1123783-56-1Upstream product

1123783-56-1Downstream Products

1123783-56-1Relevant academic research and scientific papers

HETEROCYCLIC MODULATORS OF TGR5

-

Page/Page column 58-59; 60-61, (2009/04/25)

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulation of TGR5 activity in a human or animal subject are also provided for the treatment diseases mediat

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1123783-56-1